Market Overview

Benzinga's Top Downgrades

Related TEVA
Earnings Scheduled For July 31, 2014
Will Teva Pharmaceutical (TEVA) Beat Q2 Earnings Estimates?
Sofinnova Ventures Closes $500M Fund (Fox Business)
Related RVBD
Riverbed Misses 2Q Views; Offers Outlook Above Consensus
Morgan Stanley Comments On Riverbed's Guidance Cut

Analysts at Canaccord downgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “buy” to “hold.” The target price for Teva has been raised from $50 to $45. Teva's shares closed at $37.96 yesterday.

Analysts at FBR Capital downgraded Riverbed Technology (NASDAQ: RVBD) from “outperform” to “market perform.” The target price for Riverbed has been lowered from $28 to $20. Riverbed's shares closed at $20.10 yesterday.

Analysts at Roth Capital downgraded Skullcandy (NASDAQ: SKUL) from “buy” to “neutral.” The target price for Skullcandy is set to $7. Skullcandy's shares closed at $6.61 yesterday.

CRT Capital downgraded Alpha Natural Resources (NYSE: ANR) from “buy” to “fair value.” The target price for Alpha Natural is set to $8. Alpha Natural's shares closed at $8.51 yesterday.

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Most Popular

Related Articles (RVBD + ANR)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters